Trastuzumab deruxtecan trials for HER2-positive Breast Cancer

All Trastuzumab deruxtecan trials · All HER2-positive Breast Cancer trials

Phase breakdown

Recruiting trials studying Trastuzumab deruxtecan for HER2-positive Breast Cancer

• A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
  NCT06210776 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 54 locations
• Basket Study for Oligo-metastatic Breast Cancer
  NCT05982678 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• TRUDI: TDXD+Durva in HER2+/Low IBC
  NCT05795101 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 3 locations

Common questions

How many trials study Trastuzumab deruxtecan for HER2-positive Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.